Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--I. Effects in vitro.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Neuroscience

• Publication date

  1993-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0306-4522(93)90339-HPMID 7902540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitogenic effect of basic fibroblast growth factor on embryonic ventral mesencephalic dopaminergic neurone precursors.

  1993cited by this paper
• Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

  1992cited by this paper
• Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene.

  1992cited by this paper
• Neurotrophic factors promote the maturation of developing sensory neurons before they become dependent on these factors for survival.

  1992cited by this paper
• Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection

  1992cited by this paper
• Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.

  1992cited by this paper
• A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury

  1992cited by this paper
• Stimulation of neuron survival by basic FGF and CNTF is a direct effect and not mediated by non-neuronal cells: evidence from single cell cultures.

  1992cited by this paper
• BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

  1991cited by this paper
• The duration of neurotrophic factor independence in early sensory neurons is matched to the time course of target field innervation.

  1991cited by this paper
• Acidic and basic fibroblast growth factors in the nervous system: distribution and differential alteration of levels after injury of central versus peripheral nerve

  1991cited by this paper
• Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I.

  1991cited by this paper
• The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685]

  1991cited by this paper
• Effects of basic fibroblast growth factor on survival and choline acetyltransferase development of spinal cord neurons.

  1991cited by this paper
• Recombinant human basic fibroblast growth factor (rhbFGF) induces secretion of nerve growth factor (NGF) in cultured rat astroglial cells.

  1991cited by this paper
• Stimulation of biosynthesis of nerve growth factor by acidic fibroblast growth factor in cultured mouse astrocytes.

  1991cited by this paper
• Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II

  1990cited by this paper
• Basic fibroblast growth factor (bFGF), a multifunctional growth factor for neuroectodermal cells

  1990cited by this paper
• Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

  1990cited by this paper
• Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

  1990cited by this paper
• Effect of basic fibroblast growth factor on neurons cultured from various regions of postnatal rat brain.

  1990cited by this paper
• Fibroblast growth factor stimulates the proliferation and differentiation of neural precursor cells in vitro

  1990cited by this paper
• Ability of adult rat ganglion cells to regrow axons in vitro can be influenced by fibroblast growth factor and gangliosides.

  1989cited by this paper
• Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen.

  1989cited by this paper
• Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro.

  1988cited by this paper
• Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.

  1986cited by this paper
• Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival.

  1985cited by this paper
• Neural grafting in the mammalian CNS

  1985cited by this paper
• Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries.

  1984cited by this paper
• Astrocytes, ependymal cells, and oligodendrocytes develop on schedule in dissociated cell cultures of embryonic rat brain.

  1981cited by this paper
• Statistical Principles in Experimental Design

  1963cited by this paper

• Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders

  2021cites this paper
• The role of fibroblast growth factor 2 in drug addiction

  2018cites this paper
• Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells

  2018cites this paper
• Syddansk Universitet A subpopulation of dopaminergic neurons co-expresses serotonin in ventral mesencephalic cultures but not after intrastriatal transplantation in a rat model of Parkinsons disease

  2017cites this paper
• A Subpopulation of Dopaminergic Neurons Coexpresses Serotonin in Ventral Mesencephalic Cultures but not after Intrastriatal Transplantation in a Rat Model of Parkinson's Disease

  2017cites this paper
• Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats

  2017cites this paper
• Repair of spinal cord injury by implantation of bFGF-incorporated HEMA-MOETACL hydrogel in rats

  2015cites this paper
• Transplantation of fetal ventral mesencephalic progenitor cells overexpressing high molecular weight fibroblast growth factor 2 isoforms in 6-hydroxydopamine lesioned rats.

  2015cites this paper
• Viability of olfactory ensheathing cells after hypoxia and serum deprivation: Implication for therapeutic transplantation

  2014cites this paper
• Cell replacement therapy for Huntington's disease : what we have learned from post-mortem analyses of grafted patients and mice models

  2014cites this paper
• Expression of tissue transglutaminase on primary olfactory ensheathing cells cultures exposed to stress conditions.

  2012cites this paper
• Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

  2012cites this paper
• Cell Fate Analysis of Embryonic Ventral Mesencephalic Grafts in the 6-OHDA Model of Parkinson's Disease

  2012cites this paper
• Strain Difference in the Up-Regulation of FGF-2 Protein Following a Neurotoxic Lesion of the Nigrostriatal Pathway

  2010cites this paper
• Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease

  2009cites this paper
• Olfactory ensheathing cells represent an optimal substrate for hippocampal neurons: an in vitro study

  2009cites this paper
• Schwann cell-derived factors support serotoninergic neuron survival and promote neurite outgrowth.

  2009cites this paper
• Dopamine neurons in ventral mesencephalon - Interactions with glia and locus coeruleus

  2008cites this paper
• The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system.

  2007cites this paper
• Protection of dopamine neurons by bone marrow stromal cells.

  2007cites this paper
• Olfactory ensheathing cells exert a trophic effect on the hypothalamic neurons in vitro.

  2007cites this paper
• Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2

  2007cites this paper
• Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion

  2007cites this paper
• Nucleofection Is the Most Efficient Nonviral Transfection Method for Neuronal Stem Cells Derived from Ventral Mesencephali with No Changes in Cell Composition or Dopaminergic Fate

  2006cites this paper
• Transplantation in Parkinson's disease: The future looks bright.

  2006cites this paper
• Schwann cell: a source of neurotrophic activity on cortical glutamatergic neurons in culture.

  2006cites this paper
• New Therapeutic Approaches to Parkinson’s Disease Including Neural Transplants

  2005cites this paper
• "In vitro" postnatal expression of 5-HT7 receptors in the rat hypothalamus: an immunohistochemical analysis.

  2005cites this paper
• Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease

  2005cites this paper
• Neuroinflammatory processes in Parkinson's disease.

  2005cites this paper
• Neuroprotective role of astrocytes in cerebral ischemia: Focus on ischemic preconditioning

  2005cites this paper
• Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.

  2004cites this paper
• Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.

  2004cites this paper
• Systematic differences in time of dopaminergic neuron origin between normal mice and homozygous weaver mutants

  2004cites this paper
• Specific effects of platelet derived growth factor (PDGF) on fetal rat and human dopaminergic neurons in vitro

  2004cites this paper
• Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms.

  2004cites this paper
• Alterations in the expressions of mRNA for GDNF and its receptors in the ventral midbrain of rats exposed to subchronic phencyclidine.

  2004cites this paper
• Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon

  2004cites this paper
• PARP inhibition improves the effectiveness of neural stem cell transplantation in experimental brain trauma.

  2003cites this paper
• Sphingosine 1‐phosphate induces the production of glial cell line‐derived neurotrophic factor and cellular proliferation in astrocytes

  2003cites this paper
• Dynamic expression of bFGF and TGFbeta2 in glomus cell grafts of carotid body in rat model of Parkinson disease.

  2003cites this paper
• Strategies for the augmentation of grafted dopamine neuron survival.

  2003cites this paper
• Effect of glial cell line‐derived neurotrophic factor (GDNF) co‐transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6‐hydroxydopamine (6‐OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies

  2003cites this paper
• Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease

  2003influential citation
• Models of repair mechanisms for future treatment modalities of Parkinson's disease.

  2002cites this paper
• Temporal changes in the neurotrophic environment of the denervated striatum as determined by the survival and outgrowth of grafted fetal dopamine neurons.

  2002cites this paper
• Differential regulation of glial cell line‐derived neurotrophic factor (GDNF) mRNA expression during hypoxia and reoxygenation in astrocytes isolated from stroke‐prone spontaneously hypertensive rats

  2002cites this paper
• Directions for future research.

  2002cites this paper
• [Glia conditioned medium offers protection against the toxicity induced by 6-OH-dopamine in vivo].

  2002cites this paper
• Expression of voltage-dependent calcium channels in the embryonic rat midbrain.

  2002cites this paper
• Neurotrophic factors for the investigation and treatment of movement disorders

  2001cites this paper
• Prospects for the treatment of Parkinson’s disease using neurotrophic factors

  2001cites this paper
• Molecules for Neuroprotection and Regeneration in Animal Models of Parkinson’s Disease

  2000cites this paper
• Characterization of the dopamine defect in primary cultures of dopaminergic neurons from hypoxanthine phosphoribosyltransferase knockout mice.

  2000cites this paper
• Inhibition of brain‐derived neurotrophic factor and glial cell line‐derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum

  2000cites this paper
• Glial cells and Parkinson’s disease

  2000cites this paper
• The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro.

  2000cites this paper
• Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival.

  2000cites this paper
• Dopamine cells in nigral grafts differentiate prior to implantation

  1999cites this paper
• Temporo-spatial expression of bFGF and TGFbeta2 in embryonic dopaminergic grafts in a rat model of Parkinson's disease.

  1999cites this paper
• Lack of Effect of Short-Term Depletion of Plasma Complement C3 on the Survival of Syngeneic Dopaminergic Neurons following Grafting into the Intact Rat Striatum

  1999cites this paper
• Early hypoxia modulates the phenotype of dopaminergic cells in rat di- and mesencephalic cell cultures and induces a higher vulnerability of non-dopaminergic neurons to a second hypoxic exposure.

  1999cites this paper
• Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor

  1999cites this paper
• Therapeutic Potential of Nerve Growth Factors in Parkinson’s Disease

  1999cites this paper
• Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor

  1999cites this paper
• Excitotoxicity plays a role in the death of tyrosine hydroxylase- immunopositive nigral neurons cultured in serum-free medium.

  1999cites this paper
• Somatic Gene Transfer and Cell Transplantation Strategies for Neurodegenerative Diseases

  1998cites this paper
• Trophic effect of porcine Sertoli cells on rat and human ventral mesencephalic cells and hNT neurons in vitro.

  1998cites this paper
• Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial trophic support.

  1998cites this paper
• Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures.

  1998cites this paper
• Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor.

  1998cites this paper
• Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.

  1998cites this paper
• Long-term intracerebral infusion of fibroblast growth factors restores motility and enhances F-DOPA uptake in parkinsonian monkeys.

  1998cites this paper
• Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells

  1998cites this paper
• Optimal Effectiveness of BDNF for Fetal Nigral Transplants Coincides with the Ontogenic Appearance of BDNF in the Striatum

  1998cites this paper
• Involvement of caspase‐like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6‐hydroxydopamine

  1998cites this paper
• Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?

  1998cites this paper
• Effects of fibroblast growth factors on MPTP-induced parkinsonian syndrome in mice

  1997cites this paper
• MPTP: A Dopaminergic Neurotoxin

  1997cites this paper
• Benefits and risks of hosting animal cells in the human brain

  1997cites this paper
• GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro

  1997cites this paper
• Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture.

  1996cites this paper
• Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro

  1996cites this paper
• Distribution of Fibroblast Growth Factor (FGF)-2 and FGF Receptor-1 Messenger RNA Expression and Protein Presence in the Mid-Trimester Human Fetus

  1996cites this paper
• Effects of chronic substance P treatment and intracranial fetal grafts on learning after hippocampal kainic acid lesions.

  1996cites this paper
• The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease.

  1996cites this paper
• Growth factors rescue embryonic dopamine neurons from programmed cell death.

  1996cites this paper
• Altered motor function and graft survival produced by basic fibroblast growth factor in rats with 6-OHDA lesions and fetal ventral mesencephalic grafts are associated with glial proliferation.

  1996cites this paper
• Expression of Biologically Active Basic Fibroblast Growth Factor by Genetically Modified Rat Primary Skin Fibroblasts

  1995cites this paper
• Inhibitors of Type IV Phosphodiesterases Reduce the Toxicity of MPTP in Substantia Nigra Neurons In Vivo

  1995cites this paper
• Cyclic AMP promotes the survival of dopaminergic neurons in vitro and protects them from the toxic effects of MPP+.

  1995cites this paper
• Fibroblast growth factors: Structure-activity on dopamine neurons in vitro

  1995cites this paper
• Embryo research tests NIH's mettle

  1995cites this paper
• Novel therapeutic directions for Parkinson's disease.

  1995cites this paper
• In vivo effects of kFGF on embryonic nigral grafts in a rat model of Parkinson's disease.

  1995cites this paper
• A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts.

  1995cites this paper
• Stimulation of zif/268 gene expression by basic fibroblast growth factor in primary rat striatal cultures.

  1995cites this paper
• Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors.

  1994cites this paper
• Neuroblast cell death in ovo and in culture: Interaction of ethanol and neurotrophic factors

  1994cites this paper
• Basic fibroblast growth factor induces c-fos expression in primary cultures of rat striatum.

  1994cites this paper